Nasolacrimal duct obstruction: Does it really increase the risk of amblyopia in children?
- PMID: 27609160
- PMCID: PMC5026073
- DOI: 10.4103/0301-4738.190101
Nasolacrimal duct obstruction: Does it really increase the risk of amblyopia in children?
Abstract
Purpose: To report the prevalence of amblyopia risk factors in children with congenital nasolacrimal duct obstruction.
Methods: A retrospective review of records of children with the diagnosis of congenital nasolacrimal duct obstruction (NLDO), who underwent probing from January 2009 to October 2011, was done. All of them underwent a complete ophthalmic evaluation including cycloplegic refraction and strabismus evaluation before probing.
Results: A total of 142 children were included in this study. The mean age at presentation was 22.38 months (sample standard deviation (SSD) - 15.88). Amblyopia risk factors were defined according to two sets of guidelines: The American Association for Pediatric Ophthalmology and Strabismus (AAPOS) referral criteria guidelines and the new AAPOS Vision Screening Committee guidelines. Twenty-eight (20%) children were found to have some form of amblyopia risk factor based on the referral criteria prescribed by AAPOS. However, on applying modified guidelines described by Donahue et al., to analyze the same cohort, 21 children were found to have amblyogenic risk factors. Of these 28 children, 13 had significant astigmatism (>1.50 D), 8 children had hypermetropia (>3.50 D), and six children had anisometropia (>1.50 D). One child had significant cataract (media opacity >1 mm). None of the children in this series had either myopia or strabismus.
Conclusion: Prevalence of amblyopia risk factor was found to be 20% in our study based on the older guidelines; however, it reduces to 14.78% by applying the modified guidelines. Despite this reduction, importance of a comprehensive ophthalmic examination including cycloplegic refraction in all children presenting with NLDO cannot be overstated. A close follow-up of these children is also essential to prevent the development of amblyopia.
Similar articles
-
Prevalence of amblyopia risk factors in congenital nasolacrimal duct obstruction.J AAPOS. 2010 Oct;14(5):386-8. doi: 10.1016/j.jaapos.2010.06.012. J AAPOS. 2010. PMID: 21035062
-
Prevalence of amblyopia in children undergoing nasolacrimal duct irrigation and probing.Indian J Ophthalmol. 2013 Dec;61(12):698-700. doi: 10.4103/0301-4738.124737. Indian J Ophthalmol. 2013. PMID: 24413822 Free PMC article.
-
Amblyopia risk factors in infants with congenital nasolacrimal duct obstruction.J Craniofac Surg. 2013 Jul;24(4):1123-5. doi: 10.1097/SCS.0b013e3182902b3d. J Craniofac Surg. 2013. PMID: 23851753
-
Prevalence of anisometropia and its association with refractive error and amblyopia in preschool children.Br J Ophthalmol. 2013 Sep;97(9):1095-9. doi: 10.1136/bjophthalmol-2012-302637. Epub 2013 Apr 23. Br J Ophthalmol. 2013. PMID: 23613508 Review.
-
Amblyopia due a dentigerous cyst. Case report and literature review.J Fr Ophtalmol. 2021 Oct;44(8):1249-1255. doi: 10.1016/j.jfo.2021.01.037. Epub 2021 Aug 2. J Fr Ophtalmol. 2021. PMID: 34353662 Review.
Cited by
-
Outcome of monocanalicular intubation for complex congenital nasolacrimal duct obstruction: the role of age.Rom J Ophthalmol. 2022 Jan-Mar;66(1):49-54. doi: 10.22336/rjo.2022.11. Rom J Ophthalmol. 2022. PMID: 35531458 Free PMC article.
-
Congenital Nasolacrimal Duct Obstruction and Refractive Amblyopia Risk Factors: Effect of Age at the Time of Probing.Beyoglu Eye J. 2022 Feb 18;7(1):30-34. doi: 10.14744/bej.2021.30974. eCollection 2022. Beyoglu Eye J. 2022. PMID: 35265799 Free PMC article.
-
Preferred Practice Patterns of Congenital Nasolacrimal Duct Obstruction in Jordan.Clin Ophthalmol. 2023 Aug 11;17:2309-2322. doi: 10.2147/OPTH.S421054. eCollection 2023. Clin Ophthalmol. 2023. PMID: 37593358 Free PMC article.
-
Prevalence and Treatment Outcome of Nasolacrimal Duct Obstruction in Saudi Children with Down Syndrome.Cureus. 2020 Jan 15;12(1):e6672. doi: 10.7759/cureus.6672. Cureus. 2020. PMID: 31976186 Free PMC article.
-
Amblyopia risk factors in congenital nasolacrimal duct obstruction: A longitudinal case-control study.PLoS One. 2019 Jun 13;14(6):e0217802. doi: 10.1371/journal.pone.0217802. eCollection 2019. PLoS One. 2019. PMID: 31194774 Free PMC article.
References
-
- MacEwen CJ, Young JD. Epiphora during the first year of life. Eye (Lond) 1991;5(Pt 5):596–600. - PubMed
-
- Atkinson J, Braddick O, Nardini M, Anker S. Infant hyperopia: Detection, distribution, changes and correlates-outcomes from the cambridge infant screening programs. Optom Vis Sci. 2007;84:84–96. - PubMed
-
- Kendig EL, Jr, Guerry D., 3rd The incidence of congenital impotency of the nasolacrimal duct. J Pediatr. 1950;36:212. - PubMed
-
- Paul TO, Shepherd R. Congenital nasolacrimal duct obstruction: Natural history and the timing of optimal intervention. J Pediatr Ophthalmol Strabismus. 1994;31:362–7. - PubMed
-
- Young JD, MacEwen CJ, Ogston SA. Congenital nasolacrimal duct obstruction in the second year of life: A multicentre trial of management. Eye (Lond) 1996;10(Pt 4):485–91. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical